Related Experiment Video

Updated: May 10, 2026

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

The dichotomy of inhibiting nuclear factor kappa-B in pneumonia

Edward Abraham

    Critical Care (London, England)
    |June 14, 2013
    PubMed

    Insights

    Inhibiting nuclear factor kappa-B (NF-κB) can help severe pneumonia but worsens prolonged lung injury and bacterial load in persistent infections. This suggests caution when targeting NF-κB in critical illness.

    Area of Science:

    • Immunology
    • Critical Care Medicine
    • Pulmonary Medicine

    Background:

    • Nuclear factor kappa-B (NF-κB) activation is central to inflammatory responses in severe infections.
    • NF-κB translocation to the nucleus drives gene expression of proinflammatory cytokines, potentially causing organ dysfunction.
    • Therapeutic inhibition of NF-κB is considered for critical illness but may have adverse effects in persistent infections.

    Purpose of the Study:

    • To investigate the differential effects of NF-κB inhibition in acute versus prolonged pneumonia models.
    • To evaluate the impact of NF-κB inhibition on pulmonary injury and bacterial burden in persistent pneumonia.

    Main Methods:

    • Utilized a preclinical model to study the effects of NF-κB inhibition.
    • Assessed pulmonary injury and bacterial load in response to NF-κB inhibition under different pneumonia durations.

    Main Results:

    • NF-κB inhibition showed benefit in a model of severe, rapidly progressing pneumonia.
    • Conversely, NF-κB inhibition exacerbated pulmonary injury and increased bacterial numbers in a prolonged pneumonia model.
    • These findings highlight context-dependent roles of NF-κB in infectious disease.

    Conclusions:

    • Therapeutic targeting of NF-κB may be beneficial in specific acute infectious scenarios.
    • Inhibition of NF-κB can be detrimental in persistent infections like prolonged pneumonia, worsening outcomes.
    • Caution is warranted when considering NF-κB as a therapeutic target in critically ill patients with ongoing infections.

    More Related Videos

    A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice07:43

    A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

    Published on: September 28, 2016

    Experimental Model to Evaluate Resolution of Pneumonia09:49

    Experimental Model to Evaluate Resolution of Pneumonia

    Published on: February 17, 2023

    Related Concept Videos

    NF-κB-dependent Signaling Pathway02:26

    NF-κB-dependent Signaling Pathway

    The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
    NF-κB-dependent Signaling Mechanism
    The heterodimer of NF-κB...
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    Co-activators and Co-repressors02:04

    Co-activators and Co-repressors

    Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
    NF-kB-dependent Signaling Pathway02:26

    NF-kB-dependent Signaling Pathway

    The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
    NF-κB-dependent Signaling Mechanism
    The heterodimer of NF-κB...
    Eukaryotic Transcription Inhibitors01:52

    Eukaryotic Transcription Inhibitors

    Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
    Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...